Mary J. Laughlin
University of Virginia
Dr. Laughlin is Associate Professor of Medicine and Pathology at Case Western Reserve University/Case Comprehensive Cancer Center in Cleveland, Ohio. Previously she was Assistant Professor of Medicine and Pediatrics at Duke University in North Carolina. In 1996, Dr. Laughlin co-authored with her colleagues at Duke University her first publication in the New England Journal of Medicine describing transplant outcomes in children with leukemia. Next, in 2001, she published as first author a second manuscript in the New England Journal of Medicine addressing stem cell transplant outcomes in adult leukemia patients. In 2004, her third manuscript in this prestigious publication directly compared umbilical cord blood as a new stem cell source with conventional bone marrow grafts in adult leukemia patients. In addition, Dr. Laughlin and her co-investigators have published more than 40 papers in the field of leukemia and stem cell transplantation. In addition to serving as President Elect of the International Society of Cellular Therapy (ISCT), she is also an elected member of the American Society of Hematology, the International Society for Stem Cell Research, the American Association of Blood Banks, the American Society of Blood and Marrow Transplantation, the American Association of Immunologists, and serves as advisor for additional associations and committees including the FDA and NIH. Dr. Laughlin has received numerous awards including: the Dr. Donald and Ruth Weber Goodman Professorship Chair in Innovative Cancer Therapeutics in 2006; the John J. Kelley Award in 2002 and was the first Stephen Birnbaum Translational Research Investigator both awarded by the Leukemia and Lymphoma Society of America (LLSA) in 1998, as well as being named a Clinical Scholar by the LLSA in recognition of her contributions in the field of leukemia.